SEC Filing Summary: Tharimmune, Inc. (THAR)
Business Context and Reporting Period
This Form 8-K was filed by Tharimmune, Inc. on October 10, 2025. The registrant is a Delaware corporation with its principal executive offices in Red Bank, NJ. The company is classified as an emerging growth company and its common stock trades on The Nasdaq Stock Market LLC under the symbol "THAR".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes rather than financial performance.
Material Changes
On October 10, 2025, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State. This amendment increased the total number of authorized shares of Common Stock from 250,000,000 to 1,000,000,000.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies. The document solely reports the amendment to the Articles of Incorporation.
Investor Verification Checklist
- Verify the effective date of the share authorization increase with the Delaware Secretary of State.
- Confirm the current number of issued and outstanding shares to assess the impact of the new authorization limit.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for any additional terms or conditions not summarized in the main text.
- Check for subsequent filings regarding potential capital raises utilizing the newly authorized shares.